Active ingredient
Salicylic acid 0.5%
Salicylic acid 0.5%
Acne Treatment
Use for the treatment and management of acne
For external use only. Do not get into eyes. If contact occurs, rinse eyes thoroughly with water.
When using this product skin irritation and dryness is more likely to occur if you use another topical acne medicationat the same time. If this occurs, only one medication should be used unless otherwise directed by a doctor.
Stop use and ask a doctor if excessive irritation of the skin develops
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control center right away.
Directions • clean skin thoroughly before applying this product • moisten a cotton ball, cover the entire affected area with a thin layer one to three times daily • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
Inactive ingredients allantoin, aloe barbadensis leaf juice powder, butylene glycol, camellia oleifera (green tea) leaf extract, chamomillia recuttia (matricaria) flower extract, fragrance, hamamelia virginiana (witch hazel) extract, melaleuca alternifolia (tea tree) leaf oil, menthol panthenol, pentylene glycol, polyquaternium-7 propandiol, PPG-5-ceteth-20, SD alcohol 40-B, sodium citrate, water, zinc PCA
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54473-221-04 | 2025-03-17 | C162847 | 48780-1 | 9d75b9d0-95bf-f424-e053-dadaa90a57ce | Clarity Clear Skin Essentials Deep-Cleaning Astringent |
| 54473-221-04 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-95bf-f424-e053-dadaa90a57ce | Clarity Clear Skin Essentials Deep-Cleaning Astringent |
| 54473-221-04 | 2020-03-19 | C162847 | 48780-1 | 9d75b9d0-95bf-f424-e053-dadaa90a57ce | Clarity Clear Skin Essentials Deep-Cleaning Astringent |
| 54473-221-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-95bf-f424-e053-dadaa90a57ce | Clarity Clear Skin Essentials Deep-Cleaning Astringent |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 3 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 3 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 3 | |
| CAMELLIA OLEIFERA LEAF | INACTIVE INGREDIENT | 5077EL0C60 | 3 | |
| CHAMOMILE | INACTIVE INGREDIENT | FGL3685T2X | 3 | |
| HAMAMELIS VIRGINIANA TOP | INACTIVE INGREDIENT | UDA30A2JJY | 3 | |
| MENTHOL | INACTIVE INGREDIENT | L7T10EIP3A | 3 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 3 | |
| PENTYLENE GLYCOL | INACTIVE INGREDIENT | 50C1307PZG | 3 | |
| PPG-5-CETETH-20 | INACTIVE INGREDIENT | 4AAN25P8P4 | 3 | |
| PROPANEDIOL | INACTIVE INGREDIENT | 5965N8W85T | 3 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 | |
| ZINC PIDOLATE | INACTIVE INGREDIENT | C32PQ86DH4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54473-221 | 54473-221-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| CAMELLIA OLEIFERA LEAF | 5077EL0C60 | IACT |
| CHAMOMILE | FGL3685T2X | IACT |
| HAMAMELIS VIRGINIANA TOP | UDA30A2JJY | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| PANTHENOL | WV9CM0O67Z | IACT |
| PENTYLENE GLYCOL | 50C1307PZG | IACT |
| PPG-5-CETETH-20 | 4AAN25P8P4 | IACT |
| PROPANEDIOL | 5965N8W85T | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| WATER | 059QF0KO0R | IACT |
| ZINC PIDOLATE | C32PQ86DH4 | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | JELLY / NASAL | 32.5 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SYRUP / ORAL | 7.5 mg/5ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | PASTE, DENTIFRICE / DENTAL | 4.7 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / OPHTHALMIC | NA | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION, CONCENTRATE / ORAL | 0.5 mg/1ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | LOTION / TOPICAL | 0.05 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SUSPENSION / ORAL | 1 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION / DENTAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 308e45d7-11dc-d44f-e063-6394a90ae4c3 | a665ab62-e1b5-4e7a-b015-f447e5412584 | 2025-03-17 | Warnings | a665ab62-e1b5-4e7a-b015-f447e5412584 |
Adverse event summaries are temporarily unavailable. Other product information remains available.